Publication:
H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes

dc.contributor.authorKARSLI, SEHER
dc.contributor.authorsJudes, Gaelle; Dagdemir, Aslihan; Karsli-Ceppioglu, Seher; Lebert, Andre; Echegut, Maureen; Ngollo, Marjolaine; Bignon, Yves-Jean; Penault-Llorca, Frederique; Bernard-Gallon, Dominique
dc.date.accessioned2022-03-12T20:30:03Z
dc.date.accessioned2026-01-11T14:34:38Z
dc.date.available2022-03-12T20:30:03Z
dc.date.issued2016
dc.description.abstractAim: Here, we investigated how the St Gallen breast molecular subtypes displayed distinct histone H3 profiles. Patients & methods: 192 breast tumors divided into five St Gallen molecular subtypes (luminal A, luminal B HER2-, luminal B HER2+, HER2+ and basal-like) were evaluated for their histone H3 modifications on gene promoters. Results: ANOVA analysis allowed to identify specific H3 signatures according to three groups of genes: hormonal receptor genes (ERS1, ERS2, PGR), genes modifying histones (EZH2, P300, SRC3) and tumor suppressor gene (BRCA1). A similar profile inside high-risk cancers (luminal B [HER2+], HER2+ and basal-like) compared with low-risk cancers including luminal A and luminal B (HER2-) were demonstrated. Conclusion: The H3 modifications might contribute to clarify the differences between breast cancer subtypes.
dc.identifier.doi10.2217/epi-2016-0015
dc.identifier.eissn1750-192X
dc.identifier.issn1750-1911
dc.identifier.pubmed27424567
dc.identifier.urihttps://hdl.handle.net/11424/234144
dc.identifier.wosWOS:000381034100005
dc.language.isoeng
dc.publisherFUTURE MEDICINE LTD
dc.relation.ispartofEPIGENOMICS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectbreast cancer
dc.subjectH3 modifications
dc.subjectSt Gallen molecular subtypes
dc.subjectINTERNATIONAL EXPERT CONSENSUS
dc.subjectHISTONE MODIFICATIONS
dc.subjectDNA HYPERMETHYLATION
dc.subjectDEVELOPMENTAL GENES
dc.subjectCANCER HIGHLIGHTS
dc.subjectBRCA1 EXPRESSION
dc.subjectPRIMARY THERAPY
dc.subjectESTROGEN
dc.subjectASSOCIATION
dc.subjectHER-2/NEU
dc.titleH3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage924
oaire.citation.issue7
oaire.citation.startPage909
oaire.citation.titleEPIGENOMICS
oaire.citation.volume8

Files